Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 2

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 13–24 of 391 articles

High impact NewsJun 13, 2026

FDA Clears First OTC CGM for Children: Dexcom Expands Stelo

FDA · diabetes · 4 min

Dr. Sarah Mitchell
High impact NewsJun 12, 2026

FDA priority review advances belzutifan plus pembrolizumab in adjuvant RCC

FDA · adjuvant renal cell carcinoma · 6 min

Dr. Sarah Mitchell
Critical impact NewsJun 12, 2026

FDA adds bemotrizinol to sunscreen rules, expanding U.S. UV filter options

FDA · sunburn · 5 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

FDA approves Vepdegestrant (Veppanu) for ESR1-mutated breast cancer

FDA · estrogen receptor-positive, HER2-negative breast cancer · 6 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

Sensorion pivots to SENS-601 after Regeneron’s OTOF hearing loss advance

FDA · hearing loss · 4 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

FDA Issues Guidance on Human Factors Information in Marketing Submissions

FDA · 5 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

FDA authorizes generic nitenpyram for New World screwworm in pets

FDA · New World screwworm · 5 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

FDA Approves First Interchangeable Biosimilars to Simponi and Simponi Aria

FDA · rheumatoid arthritis · 6 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

AstraZeneca expands obesity push as it invests $125M in ultrasound medicine

FDA · obesity · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 11, 2026

FDA Drug Approval: What Approval Means for Pharma Marketing and BD

FDA · 5 min

Dr. Sarah Mitchell
High impact NewsJun 9, 2026

FDA investigates Salmonella in moringa leaf powder, expands recall

FDA · Salmonella · 4 min

Dr. Sarah Mitchell
Critical impact NewsJun 8, 2026

Vanda tradipitant update: FDA re-review extends to Dec. 5, 2025

FDA · 6 min

Dr. Sarah Mitchell